Prevalent Risk Factors of Acute Coronary Syndrome in Females

Cardiovascular disease has emerged as one of the leading cause of death in women, resulting in the death of one in three women, irrespective of race and ethnicity. A growing body of research based on gender influence in cardiovascular disease is elucidating the differences between men and women. Be it clinical presentation or the response to treatment, the profile variation between the two sexes are profound. Women with ACS more commonly present with non cardiac chest pain, have negative cardiac biomarkers and are usually referred for treatment late. Despite of a lower incidence of STEMI in women than men, the morbidity and mortality rates are significantly higher in women. This can be partly attributed to the delay in treatment due to the lack of awareness and less aggressive treatment being offered to women which is evidenced by the low rates of PCI in women. The influence of sex-age interaction on mortality rates in cardiovascular disease have long been under study. Various researches have proven that younger women had a higher in patient mortality than men of the same age. As compared to young men, the prevalence of DM, CHF and late presentation was higher in young women. In addition to this, they had a higher chance of developing complications. Most of our knowledge on MI and treatment profile has been developed from studies which focused mainly on men. In the present scenario, it is important to understand